Both in Biotechnology
Scribe Therapeutics vs Century Therapeutics
Over the past year SCTX returned −48.2% and IPSC returned −24.2%; their daily moves had a correlation of 0.29.
SCTX −48.2% IPSC −24.2%Growth of $1, one year, split-adjusted
| Metric | SCTX | IPSC |
|---|---|---|
| Price | $15.42 | $1.47 |
| Market cap | $291.9M | $266.2M |
| Today | −11.58% | +0.68% |
| 1 month | −10.2% | −8.7% |
| 6 months | — | −36.4% |
| Year to date | — | +47.8% |
| 1 year | — | +154.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $119.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 73.4% |
| Short % of float | 14.6% | 23.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).